| scholarly article | Q13442814 |
| P50 | author | Christos-Konstantinos Antoniou | Q88906707 |
| Christos-Konstantinos Antoniou | Q94238504 | ||
| P2093 | author name string | Theofilos M Kolettis | |
| Antonios Sideris | |||
| Skevos Sideris | |||
| Konstantinos A Gatzoulis | |||
| Nikolaos Nikolaou | |||
| Emmanuel Kanoupakis | |||
| P2860 | cites work | Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction | Q28208692 |
| Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction | Q29040770 | ||
| Utility of electrophysiological studies to predict arrhythmic events | Q33165958 | ||
| Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias. | Q33166353 | ||
| Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial | Q34069413 | ||
| 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice | Q34319426 | ||
| Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure | Q34386004 | ||
| Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD). | Q35107904 | ||
| Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis. | Q36083893 | ||
| Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. | Q37637921 | ||
| Coronary artery disease and ventricular tachyarrhythmia: pathophysiology and treatment | Q38077323 | ||
| Prognostic scores in heart failure - Critical appraisal and practical use. | Q38423931 | ||
| Implantable Cardioverter-Defibrillators at End of Battery Life: Opportunities for Risk (Re)-Stratification in ICD Recipients. | Q38715126 | ||
| The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications | Q38903332 | ||
| Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator Implantation to Prevent Tachyarrhythmias following Acute Myocardial Infarction (PROTECT-ICD): Trial Protocol, Background and Significance | Q38927243 | ||
| Long-Term Results of Cardiac Resynchronization Therapy: A Comparison between CRT-Pacemakers versus Primary Prophylactic CRT-Defibrillators. | Q39027627 | ||
| Risk stratification for sudden cardiac death: a plan for the future | Q39262242 | ||
| Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation | Q39434749 | ||
| Out-of-hospital cardiac arrest--the relevance of heart failure. The Maastricht Circulatory Arrest Registry | Q39653403 | ||
| Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study | Q40548860 | ||
| Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure | Q40560008 | ||
| Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry | Q40638693 | ||
| Deceleration Capacity of Heart Rate Predicts Arrhythmic and Total Mortality in Heart Failure Patients. | Q40821535 | ||
| The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR. | Q41044666 | ||
| Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. | Q41144393 | ||
| Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators | Q44086151 | ||
| Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). | Q44180180 | ||
| Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT. | Q44454555 | ||
| Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work? | Q44784996 | ||
| Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community | Q44844861 | ||
| Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers | Q45147623 | ||
| Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction | Q45359883 | ||
| Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction | Q46799949 | ||
| Blunted cyclic variation of heart rate predicts mortality risk in post-myocardial infarction, end-stage renal disease, and chronic heart failure patients | Q47800248 | ||
| Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. | Q49168539 | ||
| Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction | Q49171490 | ||
| Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. | Q50744359 | ||
| Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure. | Q50769899 | ||
| Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. | Q50778872 | ||
| Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator. | Q50882479 | ||
| Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study. | Q50911711 | ||
| Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. | Q51295613 | ||
| Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score. | Q51381383 | ||
| 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. | Q51569939 | ||
| Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction. | Q53645911 | ||
| 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death | Q55983200 | ||
| Defibrillator implantation early after myocardial infarction | Q57215242 | ||
| Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both | Q57396339 | ||
| Prediction of Mode of Death in Heart Failure | Q59192126 | ||
| Time domain analysis of the signal averaged electrocardiogram in patients with a conduction defect or a bundle branch block | Q71193463 | ||
| Identification of patients with ventricular tachycardia after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring, and cardiac catheterization | Q71388094 | ||
| Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators | Q73884395 | ||
| Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction | Q74250135 | ||
| Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction | Q77335510 | ||
| Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study | Q79425794 | ||
| Noninvasive risk assessment early after a myocardial infarction the REFINE study | Q80167370 | ||
| Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era | Q81546268 | ||
| Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease | Q81610662 | ||
| Decreased scale-specific heart rate variability after multiresolution wavelet analysis predicts sudden cardiac death in heart failure patients | Q82764023 | ||
| The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention | Q83300940 | ||
| Early reperfusion therapy affects inducibility, cycle length, and occurrence of ventricular tachycardia late after myocardial infarction | Q83342334 | ||
| Post myocardial infarction risk stratification for sudden cardiac death in patients with preserved ejection fraction: PRESERVE-EF study design | Q85353623 | ||
| Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy | Q87132814 | ||
| Prognostic value of programmed ventricular stimulation for sudden death in selected high risk patients with structural heart disease and preserved systolic function | Q87644570 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| P577 | publication date | 2017-02-03 | |
| P1433 | published in | Annals of Noninvasive Electrocardiology | Q2354750 |
| P1476 | title | Arrhythmic risk stratification in heart failure: Time for the next step? | |
| P478 | volume | 22 |
| Q91719404 | Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study |
| Q64976429 | Influence of dronedarone (a class III antiarrhythmic drug) on the anticonvulsant potency of four classical antiepileptic drugs in the tonic-clonic seizure model in mice. |
| Q55359580 | Signal-averaged electrocardiography: Past, present, and future. |
| Q90666218 | Temporal changes of noninvasive electrocardiographic risk factors for sudden cardiac death in post-myocardial infarction patients with preserved ejection fraction: Insights from the PRESERVE-EF study |
Search more.